Legend Biotech Corp. (LEGN)
18.66
+0.18
(+0.95%)
USD |
NASDAQ |
Oct 19, 16:00
18.66
0.00 (0.00%)
After-Hours: 17:21
Legend Biotech Cash from Operations (Annual) : -100.46M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -100.46M |
| December 31, 2024 | -141.42M |
| December 31, 2023 | -384.47M |
| December 31, 2022 | -200.01M |
| December 31, 2021 | -197.40M |
| Date | Value |
|---|---|
| December 31, 2020 | -223.21M |
| December 31, 2019 | -83.06M |
| December 31, 2018 | 307.68M |
| December 31, 2017 | -2.376M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Gilead Sciences, Inc. | 10.02B |
| Ionis Pharmaceuticals, Inc. | -268.58M |
| Johnson & Johnson | 24.53B |
| Arbutus Biopharma Corp. | -39.64M |
| Capricor Therapeutics, Inc. | -69.81M |